Pharmaceutical investment in the United Kingdom is approaching an inflection point, as decades of scientific strength are ...

Cambridge Science Park company Immaterial Ltd – an advanced materials and engineering solutions pioneer – has raised $18.2 ...

Cambridge headquartered biopharma company AstraZeneca has invested $445 million in an upgraded manufacturing base in Texas.

Cambridge-based oncology business Mosaic Therapeutics has ended a protracted search for a new CEO with the appointment of ...

Graphene-based electronic devices pioneer Paragraf, which is located in Cambridgeshire, has scored a significant success in ...

Emmi Nicholl has just been promoted to CEO at Cambridge Angels. Tony Quested posed some key questions. How long have you been ...

AIM-listed Sareum has announced positive Phase 1 trial results for its lead autoimmune candidate, SDC-1801, and successfully ...

A pre-Budget £500m investment by the Treasury allied to fresh alliances for the University with key bodies in Hong Kong and ...

European tech law firm YPOG has opened a second UK office in Cambridge, following its recent launch in London. The move is ...

Cambridge Science Centre is toasting a decade-long partnership with locally headquartered and globally influential biopharma ...

When private investor network Cambridge Capital Group officially opened its doors with the advent of the Year 2000 billions ...

Cyclana Bio, a Cambridge biotech pioneering tissue-level approaches to women’s health, has closed a £5 million pre-seed ...